Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026
Go back to Guardant Health to Present 28 Abstracts Highlighting Advances in Tumor Typing, Therapy Selection and Expanded Utility of Multiomic Tissue and Liquid Biopsy Testing at AACR 2026| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 128.83 -2.95 (2.24%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $131.78 | 52 Week High | $5.84 | |||
| Open | $131.16 | 52 Week Low | $5.49 | |||
| Day High | $132.07 | P/E | N/A | |||
| Day Low | $125.12 | EPS | $0.00 | |||
| Volume | 1,444,664 | |||||
